Tumor Cell Quantification
Tumor Cell Quantification - Related Videos
10:31
The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
0 Views •
Cited by 11 •
2016
This protocol demonstrates how to generate fluorescently marked, genetically defined clonal tumors in the Drosophila eye/antennal imaginal discs (EAD). It describes how to dissect the EAD and brain from the third instar larvae and how to process them to visualize and quantify gene expression changes and tumor invasiveness.
06:09
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
0 Views •
2020
Here, we describe a simple and inexpensive method that allows the quantification of adhesive tumor cells to lymph node (LN) cryosections. LN-adherent tumor cells are readily identified by light microscopy and confirmed by a fluorescence-based method, giving an adhesion index that reveals the tumor cell-binding affinity to LN parenchyma.
11:00
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
0 Views •
Cited by 14 •
2020
Here, we describe a simple and accessible strategy for visualizing, quantifying, and mapping immune cells in formalin-fixed paraffin-embedded tumor tissue sections. This methodology combines existing imaging and digital analysis techniques with the purpose of expanding the multiplexing capability and multiparameter analysis of imaging assays.
04:28
Lung Tumor Cell Recruitment Assay
0 Views •
2019
This manuscript describes a method to quantify tumor cell accumulation in the lungs in an animal model of tumor metastasis.
07:12
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
0 Views •
Cited by 29 •
2016
Bioluminescence imaging is a well-known tool for localizing tumors and metastases, but quantification of these images often requires complex calculations and particular instruments. We describe the easy-to-use luminoscore method, based on precise acquisition conditions, requiring no calculations, and enabling tumor burden and treatment response to be monitored in mouse models.
FAQs
These measurements answer related but distinct questions. Cell number indicates how many cancer cells are present, density describes their concentration within a specimen or analyzed area, and proportion shows their representation among the measured population. Selecting the appropriate metric helps researchers compare tumor burden, cellular composition, and biological responses without treating all measurements as interchangeable.
Identification features determine which cells contribute to the measurement. Morphology can distinguish cells based on observable characteristics, whereas molecular markers provide tumor-associated signals for classification. Using these features helps separate cancer cells from other populations and supports analysis of heterogeneous samples, where counting every visible cell could misrepresent tumor composition or treatment-related changes.
Imaging-based approaches evaluate specimens through visual analysis, often using segmentation to delineate and count cells or regions. Flow cytometry provides another route for measuring identified cell populations after specimen preparation. The methods differ in how cells are represented and analyzed, so the choice should match whether the study emphasizes spatial specimen information or population-level cellular measurements.
Defined conditions make measurements more comparable across samples and experimental groups. Changes in specimen handling, identification criteria, imaging or counting procedures, and analysis settings can influence the recorded number, density, or proportion of cells. Controlling these conditions strengthens interpretation of differences in tumor burden and helps distinguish biological responses from variation introduced by the measurement process.
A typical workflow begins by preparing a specimen through separation or imaging, followed by identification of tumor cells using morphology or molecular markers. Researchers then apply counting, image segmentation, or flow cytometry under specified conditions and record the resulting measurement. This sequence connects sample preparation and cell classification with quantitative comparisons among experimental groups.
The measurement supports several cancer research applications, including tumor growth analysis, treatment-response studies, invasion and metastasis assays, and characterization of heterogeneous cell populations. By tracking changes in cell number, density, or proportion, investigators can relate experimental conditions to disease progression, therapeutic effectiveness, and mechanisms of cancer biology.